247AD201 CELIA – A Randomized, Double-Blind, Placebo-Controlled, Parallel-Group Study to Assess the Efficacy, Safety, and Tolerability of BIIB080 in Subjects with Mild Cognitive Impairment Due to Alzheimer’s Disease or Mild Alzheimer’s Disease Dementia

A randomized, two period, double-blind placebo-controlled and open label, multicenter extension study to determine the long-term safety and tolerbility of JNJ-54861911 in subjects in the early Alzheimer's Disease Spectrum

Identifizierung von funktionellen Biomarkern für Tinnitus und Hyperakusis im Tiermodell und Menschen

A Multicenter, Follow-up Study to Assess Long-Term Electrophysiologic and Clinical Outcomes in Subjects Previously Enrolled in Study 215ON201